![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: NIPAL2 |
Gene summary for NIPAL2 |
![]() |
Gene information | Species | Human | Gene symbol | NIPAL2 | Gene ID | 79815 |
Gene name | NIPA like domain containing 2 | |
Gene Alias | NPAL2 | |
Cytomap | 8q22.2 | |
Gene Type | protein-coding | GO ID | GO:0006810 | UniProtAcc | Q9H841 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
79815 | NIPAL2 | HTA11_3410_2000001011 | Human | Colorectum | AD | 4.47e-04 | -3.61e-01 | 0.0155 |
79815 | NIPAL2 | HTA11_1938_2000001011 | Human | Colorectum | AD | 9.58e-03 | 4.00e-01 | -0.0811 |
79815 | NIPAL2 | HTA11_347_2000001011 | Human | Colorectum | AD | 6.33e-05 | 4.21e-01 | -0.1954 |
79815 | NIPAL2 | HTA11_866_3004761011 | Human | Colorectum | AD | 7.73e-06 | -4.30e-01 | 0.096 |
79815 | NIPAL2 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 6.10e-08 | -2.72e-01 | 0.294 |
79815 | NIPAL2 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 6.14e-07 | -3.90e-01 | 0.3005 |
79815 | NIPAL2 | A015-C-203 | Human | Colorectum | FAP | 2.95e-24 | -3.86e-01 | -0.1294 |
79815 | NIPAL2 | A015-C-204 | Human | Colorectum | FAP | 6.20e-03 | -2.76e-01 | -0.0228 |
79815 | NIPAL2 | A002-C-201 | Human | Colorectum | FAP | 3.66e-07 | -3.39e-01 | 0.0324 |
79815 | NIPAL2 | A002-C-203 | Human | Colorectum | FAP | 1.13e-02 | -7.04e-02 | 0.2786 |
79815 | NIPAL2 | A001-C-119 | Human | Colorectum | FAP | 8.75e-06 | -4.12e-01 | -0.1557 |
79815 | NIPAL2 | A001-C-108 | Human | Colorectum | FAP | 2.40e-13 | -2.97e-01 | -0.0272 |
79815 | NIPAL2 | A002-C-205 | Human | Colorectum | FAP | 1.77e-13 | -4.02e-01 | -0.1236 |
79815 | NIPAL2 | A001-C-104 | Human | Colorectum | FAP | 4.58e-02 | -1.59e-01 | 0.0184 |
79815 | NIPAL2 | A015-C-005 | Human | Colorectum | FAP | 5.64e-03 | -3.10e-01 | -0.0336 |
79815 | NIPAL2 | A015-C-006 | Human | Colorectum | FAP | 4.15e-10 | -3.97e-01 | -0.0994 |
79815 | NIPAL2 | A015-C-106 | Human | Colorectum | FAP | 4.89e-11 | -2.20e-01 | -0.0511 |
79815 | NIPAL2 | A002-C-114 | Human | Colorectum | FAP | 4.85e-11 | -4.00e-01 | -0.1561 |
79815 | NIPAL2 | A015-C-104 | Human | Colorectum | FAP | 1.09e-29 | -5.05e-01 | -0.1899 |
79815 | NIPAL2 | A001-C-014 | Human | Colorectum | FAP | 3.85e-11 | -2.06e-01 | 0.0135 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:1903830 | Colorectum | FAP | magnesium ion transmembrane transport | 7/2622 | 17/18723 | 5.62e-03 | 3.61e-02 | 7 |
GO:0015693 | Colorectum | FAP | magnesium ion transport | 7/2622 | 18/18723 | 8.10e-03 | 4.77e-02 | 7 |
GO:19038301 | Colorectum | CRC | magnesium ion transmembrane transport | 7/2078 | 17/18723 | 1.46e-03 | 1.57e-02 | 7 |
GO:00156931 | Colorectum | CRC | magnesium ion transport | 7/2078 | 18/18723 | 2.16e-03 | 2.11e-02 | 7 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
NIPAL2 | SNV | Missense_Mutation | novel | c.239N>G | p.His80Arg | p.H80R | Q9H841 | protein_coding | tolerated(0.18) | benign(0) | TCGA-FI-A2F4-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
NIPAL2 | deletion | Frame_Shift_Del | novel | c.974delN | p.Leu325TrpfsTer62 | p.L325Wfs*62 | Q9H841 | protein_coding | TCGA-EY-A1H0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | taxol | SD | ||
NIPAL2 | SNV | Missense_Mutation | novel | c.583N>G | p.Ile195Val | p.I195V | Q9H841 | protein_coding | tolerated(0.29) | benign(0.006) | TCGA-2Y-A9H1-01 | Liver | liver hepatocellular carcinoma | Male | <65 | I/II | Unknown | Unknown | PD |
NIPAL2 | SNV | Missense_Mutation | novel | c.299N>A | p.Gly100Glu | p.G100E | Q9H841 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-UB-AA0U-01 | Liver | liver hepatocellular carcinoma | Male | <65 | I/II | Unknown | Unknown | PD |
NIPAL2 | SNV | Missense_Mutation | novel | c.308G>T | p.Gly103Val | p.G103V | Q9H841 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-05-4249-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
NIPAL2 | SNV | Missense_Mutation | c.541N>A | p.Gln181Lys | p.Q181K | Q9H841 | protein_coding | tolerated(0.39) | possibly_damaging(0.474) | TCGA-18-4721-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
NIPAL2 | SNV | Missense_Mutation | novel | c.266T>C | p.Leu89Pro | p.L89P | Q9H841 | protein_coding | deleterious(0.02) | probably_damaging(0.992) | TCGA-O2-A52W-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
NIPAL2 | SNV | Missense_Mutation | novel | c.864C>G | p.Ile288Met | p.I288M | Q9H841 | protein_coding | deleterious(0.05) | benign(0.282) | TCGA-BA-5152-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
NIPAL2 | SNV | Missense_Mutation | c.295N>A | p.Val99Met | p.V99M | Q9H841 | protein_coding | deleterious(0.01) | benign(0.223) | TCGA-BR-8487-01 | Stomach | stomach adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
NIPAL2 | SNV | Missense_Mutation | rs766112635 | c.421N>A | p.Ala141Thr | p.A141T | Q9H841 | protein_coding | tolerated(0.17) | benign(0.015) | TCGA-BR-8680-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Chemotherapy | oxaliplatin | CR |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |